Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV) (Q77292948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Bialer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S I Johannessen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

H J Kupferberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R H Levy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P Loiseau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

E Perucca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

The disposition of valproyl glycinamide and valproyl glycine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Protection against dendrotoxin-induced clonic seizures in mice by anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Effects of the anticonvulsant losigamone and its isomers on the GABAA receptor system

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Regional cerebral blood flow in man manipulated by direct vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

1 reference

7 January 2021

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H2(15)O blood flow imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

1 reference

7 January 2021

Efficacy and safety of zonisamide: results of a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Feasibility and safety of vagal stimulation in monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Oxcarbazepine: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Left vagal nerve stimulation in children with refractory epilepsy. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vigabatrin. Clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: comparison with the structural analogs dizocilpine and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Progress report on new antiepileptic drugs. A summary of the Second Eilat Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Effects of vagal stimulation on experimentally induced seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

Inhibition of experimental seizures in canines by repetitive vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900108-9

7 January 2021

10.1016/S0920-1211(98)00108-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194110%20AND%20SRC:MED&resulttype=core&format=json